Immune thrombocytopenic purpura - Current management practices

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 12, 2004, Pages 2515-2527

  Sandler, S Gerald ^a   Tutuncuoglu, S Osman ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Autoimmune diseases; ITP; IV RhIg; IVIg; Purpura; Rituximab; Splenectomy; Thrombocytopenia

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DOXORUBICIN; IMMUNOGLOBULIN; LIPOSOME; PNEUMOCOCCUS VACCINE; PREDNISONE; PROTEIN A; RECOMBINANT ALPHA2B INTERFERON; RHESUS ANTIBODY; RHESUS D ANTIBODY; RITUXIMAB; THROMBOPOIETIN; VINCA ALKALOID;

ASEPTIC MENINGITIS; CATARACT; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG MEGADOSE; FLU LIKE SYNDROME; HIRSUTISM; HUMAN; HYPERACTIVITY; HYPERADRENOCORTICISM; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSOMNIA; KIDNEY FAILURE; MOOD DISORDER; MOON FACE; OSTEOPOROSIS; OUTCOMES RESEARCH; PATIENT CARE; PEPTIC ULCER; PERSONALITY DISORDER; REMISSION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SIDE EFFECT; SPLENECTOMY; THROMBOCYTE COUNT;

EXPERT TESTIMONY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PURPURA, THROMBOCYTOPENIC; RHO(D) IMMUNE GLOBULIN; SPLENECTOMY; THROMBOCYTOPENIA;

EID: 10644287787     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.12.2515     Document Type: Review

References (116)

1. HARRINGTON WJ, MINNICH V, HOLLINGSWORTH JW et al.: Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J. Lab. Clin. Med. (1951) 115 636-645.
2. MCFARLAND J: Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev. (2002) 16(1):1-2.
3. IIb. Blood (2001) 97 2171-2172.
4. KUWANA M, KABURAKI J, KITASATO H et al.: Immunodominant epitopes on glycoproteins IIb-IIIa. recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood (2001) 98 130-139.
5. CHAN H, MOORE JC, FINCH CN et al.: The IgG subclasses of platelet-associated autoantibodies detected against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura. Br. J. Haematol. (2003) 122:818-824.
6. GERNSHEIMER T, STRATTON J, BALLEM PJ, SLICHTER SJ: Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N. Engl. J. Med. (1989) 320(15):974-980.
7. HURLIMANN-FORSTER M, STEINER B, VON FELTEN A: Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using the purified glycoproteins complexes GPIIb/IIIa and GPIb/IX as antigens. Br. J. Haematol. (1997) 98 328-335.
8. SAVASMAN CM, SANDLER SG: Serologic aspects of treating immune thrombocytopenic purpura using intravenous Rh immune globulin. Immunohematology (2001) 17(4):106-110.
9. WILLIAMS Y, LYNCH S, MCCANN S et al.: Correlation of platelet FcγRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura. Br. J. Haematol. (1998) 101 779-782.
10. GASBARRINI A, FRANCESCHI F, TARTAGLIONE R, LANDOLFI R, POLA P, GASBARRINI G: Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 352 9131):878.
11. EMILIA G, LONGO G, LUPPI M et al.: Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood (2001) 97(3):812-814.
12. VENERI D, FRANCHINI M, GOTTARDI M et al.: Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica (2002) 87(11):1177-1779.
13. KOHDA Y, KUGA T, KOGAWA K et al.: Effect of Helicobacter pyiori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br. J. Haematol. (2002) 118 2):584-588.
14. HASHINO S, MORI A, SUZUKI S et al.: Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int. J. Hematol. (2003) 77(2):188-191.
15. MICHEL M, COOPER N, JEAN C, FRISSORA C, BUSSEL JB: Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood (2004) 103(3):890-896.
16. JARQUE I, ANDREU R, LLOPIS I et al.: Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. (2001) 115(4):1002-1003.
17. MCCRAE KR: Helicobacter pylori and ITP: many questions, few answers. Blood(2004) 103(3):752-753.
18. SANDLER SG: Immune thrombocytopenic purpura: an update for immunohematologists. Immunohematology (2004) 20(2):112-117.
19. OLSSON B, ANDERSSON PO, JERNAS M et al.: T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat. Med. (2003) 9(9):1123-1124.
20. KUHNE T, IMBACH P, BOLTON-MAGGS PH et al., and the INTERCONTINENTAL CHILDHOOD ITP STUDY GROUP: Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet (2001) 358(9299):2122-2125.
21. BLANCHETTE VS, CARCAO M: Childhood acute immune thrombocytopenic purpura: 20 years later. Semin. Thromb. Hemost. (2003) 29(6):605-617.
22. IYORI H, BESSHO F, OOKAWA H et al., and the JAPANESE STUDY GROUP ON CHILDHOOD ITP: Intracranial hemorrhage in children with immune thrombocytopenic purpura. Ann. Hematol. (2000) 79 12):691-695.
23. BUTROS LJ, BUSSEL JB: Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J. Pediatr. Hematol. Oncol. (2003) 25(8):660-664.
24. NUGENT DJ: Controversies in the treatment of pediatric immune thrombocytopenias. Blood Rev. (2002) 16(1):15-17.
25. FREDERIKSEN H, SCHMIDT K: The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood (1999) 94(3):909-913.
26. NEYLON AJ, SAUNDERS PW, HOWARD MR, PROCTOR SJ, TAYLOR PR, on behalf of THE NORTHERN REGION HAEMATOLOGY GROUP: Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br. J. Haematol. (2003) 122(6):966-974.
27. RAIFE TJ, OLSON JD, LENTZ SR: Platelet antibody testing in idiopathic thrombocytopenic purpura. Blood (1997) 89:112-114.
28. GEORGE JN: Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient? J. Pediatr. (2000) 137(5):598-600.
29. GEORGE JN, WOOLF SH, RASCOB GE et al.: idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 88 340.
30. LILLEYMAN J: Medical nemesis and childhood ITP. Br. J. Haematol. (2003) 123(4):586-589.
31. DICKERHOFF R, VON RUECKER A: The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J. Pediatr. (2000) 137(5):629-632.
32. BOLTON-MAGGS P, TARANTINO MD, BUCHANAN GR, BUSSEL JB, GEORGE JN: The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J. Pediatr. Hematol. Oncol. (2004) 26(2):146-151.
33. DOAN CA, BOURONCLE BA, WISEMAN BK: Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann. Intern. Med. (1960) 53:861-876.
34. MUELLER-ECKHARDT C: Idiopathic thrombocytopenic purpura (ITP): clinical and immunologic considerations. Semin. Thromb. Hemost. (1977) 3(3):125-159.
35. BRITISH COMMITTEE FOR STANDARDS IN HAEMATOLOGY GENERAL HAEMATOLOGY TASK FORCE: Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br. J. Haematol. (2003) 120(4):574-596.
36. KAZNELSON P: Verschwinden den haemorrhagischen diathese bei einem fallen von essentieller thrombopenia (Frank) nach milz extripation. Splenogene thrombolitsche purpura. Wien Klin. Wochenschr. (1916) 29:1451-1454.
37. WINTROBE MM: ACTH and cortisone in hemopoietic disorders. Editorial. Am. J. Med. (1950) 9(6):715-717.
38. SANDLER SG: The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura. Semin. Hematol. (2000) 37(Suppl. 1):10-12.
39. 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br. J. Haematol. (1997) 97(3):547-550.
40. SHULMAN NR, WEINRACH RS, LIBRE EP et al.: The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans. Assoc. Am. Physicians. (1965) 78:374-390.
41. BUSSEL J, CINES D: Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia, and post-transfusion purpura. In: Hematology Basic Principles and Practice. Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (Eds), Churchill Livingstone, Inc., New York, NY, USA (1995):1849-1870.
42. COON WW: Splenectomy for idiopathic thrombocytopenic purpura. Surg. Gynecol. Obstet. (1987) 164(3):225-229.
43. BELL WR Jr: Role of splenectomy in immune (idiopathic) thrombocytopenic purpura. Blood Rev. (2002) 16(1):39-41.
44. RODEGHIERO F, FREZZATO M, SCHIAVORTO C et al.: Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura. Haematologica (1992) 77:253-256.
45. ZARRABI MD, ROSNER F: Serious infections in adults following splenectomy. Arch. Int. Med. (1984) 144:1421-1424.
46. BEATTIE JF, MICHELSON ML, HOLMAN PJ: Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N. Engl. J. Med. (2002) 347(9):697-698.
47. KONRADSEN HB, HENRICHSEN J: Pneumococcal infections in splenectomized children are preventable. Acta. Paediatr. Scand. (1991) 80(4):423-427.
48. DAVIES JM, BARNES R, MILLIGAN D, BRITISH COMMITTEE FOR STANDARDS IN HAEMATOLOGY. WORKING PARTY OF THE HAEMATOLOGY/ONCOLOGY TASK FORCE: Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin. Med. (2002) 2(5):440-443.
49. SCHILLING RF: Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann. Intern. Med. (1995) 22(3):187-188.
50. SZOLD A, KAIS H, KEIDAR A, NADAV L, ELDOR A, KLAUSNER JM: Chronic idiopathic thrombocytopenic purpura (ITP) is a surgical disease. Surg. Endosc. (2000) 16(1):155-158.
51. BEHAM ES, TAFT LI: Idiopathic thrombocytopenic purpura in children: Results of steroid therapy and splenectomy. Aust. Paediat. J. (1972) 8(6):311-317.
52. BROOKS PL, O'SHEA MJ, PRYOR JP: Splenectomy in the treatment of idiopathic thrombocytopenic purpura. Br. J. Surg. (1969) 56 11):861-863.
53. GROSFELD JL, NAFFIS D, BOLES ET Jr, NEWTON WA Jr: The role of splenectomy in neonatal idiopathic thrombocytopenic purpura. J. Pediatr. Surg. (1970) 5(2):166-171.
54. DAVIS PW, WILLIAMS DA, SHAMBERGER RC: Immune thrombocytopenia: surgical therapy and predictors of response. J. Pediatr. Surg. (1991) 26(4):407-412.
55. ZERELLA JT, MARTIN LW, LAMPKIN BC: Emergency splenectomy for idiopathic thrombocytopenic purpura in children. J. Pediatr. Surg. (1978) 13(3):243-246.
56. WANACHIWANAWIN W, PIANKIJAGUM A, SINDHVANANDA K, VATHANOPHAS V, VISUDHIPHAN S, NA-NAKORN S: Emergency splenectomy in adult idiopathic thrombocytopenic purpura. A report of seven cases. Arch. Intern. Med. (1989) 149(1):217-219.
57. FRIEDMAN RL, FALLAS MJ, CARROLL BJ, HIAT JR, PHILLIPS EH: Laparoscopic splenectomy for ITP The gold standard. Surg. Endosc. (1996) 10:991-995.
58. CHAPMAN WH 3rd, ALBRECHT RJ, KIM VB, YOUNG JA, CHITWOOD WR Jr.: Computer-assisted laparoscopic splenectomy with the da Vinci surgical robot. J. Laparoendosc. Adv. Surg. Teech. A. (2000) 12 3):155-159.
59. SCHLINKERT RT, BRAICH TA: Laparoscopic assisted splenectomy for treatment of presumed immune thrombocytopenic purpura: initial results. Mayo Clin. Proc. (1994) 69:422-424.
60. PARK AE, BIRGISSON G, MASTRANGELO MJ, MARCACCIO MJ, WITZKE DB: Laparoscopic splenectomy: outcomes and lessons learned from over 200 cases. Surgery (2000) 128(4):660-667.
61. MARCACCIO MJ: Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura. Semin. Hematol. (2000) 37 3):267-274.
62. DUPERIER T, BRODY F, FELSHER J, WALSH RM, ROSEN M, PONSKY J: Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch. Surg. (2004) 139 1):61-66.
63. VERHEYDEN CN JR, BEART RW, CLIFTON MD, PHYLIKY RL: Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin. Proc. (1978) 53(7):442-446.
64. WALLACE D, FROMM D, THOMAS D: Accessory splenectomy for idiopathic thrombocytopenic purpura. Surgery (1982) 91 134-136.
65. FACON T, CAULIER MT, FENAUX P et al.: Accessory spleen in recurrent chronic immune thrombocytopenic purpura. Am. J. Hematol. (1992) 41:184-189.
66. PAWELSKI S, KONOPKA L, ZDZIECHOWSKA H: Recurrence of thrombocytopenia in patients splenectomized for idiopathic thrombocytopenic purpura. Blut (1981) 43(6):355-360.
67. HANDIN RI, STOSSEL TP: Effect of corticosteroid therapy on the phagocytosis of antibody-coated platelets by human leukocytes. Blood (1978) 51(5):771-779.
68. ANDERSEN JC: Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N. Engl. J. Med. (1994) 330(22):1560-1564.
69. FUJISAWA K, TANI P, PIRO L, MCMILLAN R: The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood (1993) 81(11):2872-2877.
70. KITCHENS CS, PENDERGAST JF: Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood (1986) 67(1):203-206.
71. IMBACH P, BARANDUM E, D'APUZZO V et al.: High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet (1981) 1:1228-1230.
72. GUGLER E: Die klindlichen thrombocytopenien. In: Pad Fortbildungskurse. Rossi E (Ed.). Karger, Basel, Switzerland (1964):143-158.
73. SANDLER SG: Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin. Transfus. Med. Rev. (2001) 15(1):67-76.
74. BLANCHETTE V, SEMPLE JW, FREEDMAN JJL: Intravenous immune globulin and Rh immunoglobulin as immunomodulators as autoimmunity to blood elements. In: Autoimmune Disorders of Blood. Silberstein LE (Ed.). American Association of Blood Banks, Bethesda, MD, USA (1996):35-77.
75. FEHR J, HOFMANN V, KAPPELER U: Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N. Engl. J. Med. (1982) 306 1254-1258.
76. BUSSEL JB, FITZGERALD-PEDERSEN J, FELDMAN C: Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better. Am. J. Hematol. (1990) 33(3):184-188.
77. BLANCHETTE VS, LUKE B, ANDREW M et al.: A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J. Pediatr. (1993) 123(6 ):989-995.
78. DUHEM C, DICATO MA, RIES F: Side-effects of intravenous immune globulins. Clin. Exp. Immunol. (1994) 97(Suppl. 1):79-83.
79. SANDLER SG, NOVAK SC, ROLAND B: The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin. Am. J. Hematol. (2000) 63 3):156-158.
80. SEKUL EA, CUPLER EJ, DALAKAS MC: Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann. Intern. Med. (1994) 121(4):259-262.
81. BUSSEL JB, GRAZIANO JN, KIMBERLY RP, PAHWA S, ALEDORT LM: Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood (1991) 77 9):1884-1893.
82. SALAMA A, MUELLER-ECKHARDT C, KIEFEL V: Effect of intravenous immunoglobulin in immune thrombocytopenia: competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet (1983) 2:193-195.
83. SANDLER SG: Intravenous Rh immune globulin for treating immune thrombocytopenic purpura. Curr. Opin. Hematol. (2001) 8 6):417-420.
84. NEWMAN GC, NOVOA MV, FODERO EM, LESSER ML, WOLOSKI BMR, BUSSEL JB: A dose of 75 μg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura. Br. J. Haematol. (2001) 112(4):1076-1078.
85. COOPER N, WOLOSKI BM, FODERO EM et al.: Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood (2002) 99(6):1922-1927.
86. GAINES AR: Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho (D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood (2000) 95 8):2523-2529.
87. o [D] immune globulin [human] (WinRho SDF™): suspected hemolytic/renal adverse reactions. CMAJ (2000) 163(7):881-885.
88. BLANCHETTE V, IMBACH P, ANDREW M et al.: Randomised trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 344(8924):703-707.
89. CINES DB, BLANCHETTE VS: Medical progress: immune thrombocytopenic purpura. N. Engl. J. Med. (2002) 346 13):995-1008.
90. STASI R, PAGANO A, STIPA E, AMADORI S: Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood (2001) 98 4):952-957.
91. STASI R, STIPA E, FORTE V, MEO P, AMADORI S: Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood (2002) 99 10):3872-3873.
92. SHANAFELT TD, MADUEME HL, WOLF RC, TEFFERI A: Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin. Proc. (2003) 78(11):1340-1346.
93. GIAGOUNIDIS AA, ANHUF J, SCHNEIDER P et al.: Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur. J. Haemato. (2002) 69(2):95-100.
94. BENGTSON KL, SKINNER MA, WARE RE: Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura. J. Pediatr. (2003) 143(5):670-673.
95. HEELAN BT, TORMEY V, AMLOT P, PAYNE E, MEHTA A, WEBSTER AD: Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. Br. J. Haematol. (2002) 118(4):1078-1081.
96. COHEN Y, POLLIACK A: Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10 years duration after only two infusions of rituximab. Hematol. J. (2002) 3 1):61-62.
97. PATEL K, BERMAN J, FERBER A, CARO J: Refractory autoimmune thrombocytopenic purpura treatment with Rituximab. Am. J. Hematol. (2001) 67(1):59-60.
98. SHVIDEL L, KLEPFISH A, BERREBI A: Successul treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma. Am. J. Hematol. (2001) 67 3):213-214.
99. FAURSCHOU M, HASSELBALCH HC, NIELSEN OJ: Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia. Eur. J. Haematol. (2001) 66(6):408-411.
100. AGGARWAL A, CATLETT JP: Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura. South. Med. J. (2002) 95(10):1209-1212.
101. NARANG M, PENNER JA, WILLIAMS D: Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab). Am. J. Hematol. (2003) 74(4):263-267.
102. RIKSEN NP, KEUNING JJ, VREUGDENHIL G: Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura. Neth. J. Med. (2003) 61(7):262-265.
103. PEROTTA A, SUNNEBERG TA, SCOTT J et al.: Rituxan in the treatment of chronic idiopathic thrombocytopenic purpura. Blood (1999) 94:49a (Abstract).
104. BUSSEL JB: Novel approaches to refractory immune thrombocytopenic purpura. Blood. Rev. (2002) 16(1):31-36.
105. MCMILLAN R: Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann. Intern. Med. (1997) 126 4):307-314.
106. AHN YS, ROCHA R, MYLVAGANAM R, GARCIA R, DUNCAN R, HARRINGTON WJ: Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women. Ann. Intern. Med. (1989) 111(9):723-729.
107. GODEAU B, DURAND JM, ROUDOT-THORAVAL F et al.: Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases. Br. J. Haematol. (1997) 97(2):336-339.
108. FACON T, CAULIER MT, WATTEL E, JOUET JP, BAUTERS F, FENAUX P: A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients. Br. J. Haematol. (1994) 86(3):678-680.
109. EMILIA G, MORSELLI M, LUPPI M et al.: Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. Blood (2002) 99(4):1482-1485.
110. WILLIS F, MARSH JC, BEVAN DH et al.: The effect of treatment with campath-1H in patients with autoimmune cytopenias. Br. J. Haematol. (2001) 114(4):891-898.
111. COSGRIFF TM, BLACK ML, STEIN W 3rd: Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin. Am. J. Hematol. (1998) 57(1):85-86.
112. SNYDER HW, COCHRAN SK, BALINT JP, JONES FR: Immune modulation leading to resolution of acute and treatment-resistant immune thrombocytopenic purpura in patients treated with protein A immunoadsorption. Therapeutic Plasmapheresis (1993) 12 611-614.
113. DUBBELD P, HILLEN HF, SCHOUTEN HC: Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP) Eur. J. Haematol. (1994) 52(4):233-235.
114. HUHN RD, FOGARTY PF, NAKAMURA R et al.: High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood (2003) 101(1):71-77.
115. VON DEM BORNE A, FOLMAN C, VAN DEN OUDENRIJN S, LINTHORST G, DE JONG S, DE HAAS M: The potential role of thrombopoietin in idiopathic thrombocytopenic purpura. Blood Rev. (2002) 16(1):57-59.
116. MCMILLAN R, DURETTE C: Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood (2004) 104 4):956-960.